OBJECTIVE AND DESIGN: To investigate the potential protective effects of chlorogenic acid (CGA) on acute liver injury caused by lipopolysaccharide (LPS) in mice. MATERIALS AND METHODS: C57BL/6J mice were pretreated with CGA (50 mg/kg, intraperitoneally) once per day for 5 days before an overnight LPS challenge (30 mg/kg, intraperitoneally). Severity of liver injury was assessed by histological analysis and determination of serum ALT and AST levels. Expression and activation of key regulators involved in the inflammatory response were determined, respectively, by real-time RT-PCR and western blotting. RESULTS: In contrast to the yellow color of the liver in LPS-treated mice, CGA maintained the normal reddish appearance of the liver. Histological analysis indicated that CGA attenuated the infiltration of neutrophil cells and the necrosis of hepatocytes. CGA also decreased the elevated plasma levels of ALT and AST. At the transcriptional level, CGA pretreatment suppressed hepatic mRNA expression of toll-like receptor 4 (TLR4), TNF-alpha and NF-kappaB p65 subunit. In contrast, mRNA level of the transcriptional coactivator PGC-1alpha was restored by CGA. Finally, CGA reduced the phosphorylation of NF-kappaB p65 subunit in the liver. CONCLUSION: Our data suggest that CGA has remarkable hepatoprotective effects on LPS-induced liver injury and that the possible mechanism is related to its anti-inflammatory action.
OBJECTIVE AND DESIGN: To investigate the potential protective effects of chlorogenic acid (CGA) on acute liver injury caused by lipopolysaccharide (LPS) in mice. MATERIALS AND METHODS: C57BL/6J mice were pretreated with CGA (50 mg/kg, intraperitoneally) once per day for 5 days before an overnight LPS challenge (30 mg/kg, intraperitoneally). Severity of liver injury was assessed by histological analysis and determination of serum ALT and AST levels. Expression and activation of key regulators involved in the inflammatory response were determined, respectively, by real-time RT-PCR and western blotting. RESULTS: In contrast to the yellow color of the liver in LPS-treated mice, CGA maintained the normal reddish appearance of the liver. Histological analysis indicated that CGA attenuated the infiltration of neutrophil cells and the necrosis of hepatocytes. CGA also decreased the elevated plasma levels of ALT and AST. At the transcriptional level, CGA pretreatment suppressed hepatic mRNA expression of toll-like receptor 4 (TLR4), TNF-alpha and NF-kappaB p65 subunit. In contrast, mRNA level of the transcriptional coactivator PGC-1alpha was restored by CGA. Finally, CGA reduced the phosphorylation of NF-kappaB p65 subunit in the liver. CONCLUSION: Our data suggest that CGA has remarkable hepatoprotective effects on LPS-induced liver injury and that the possible mechanism is related to its anti-inflammatory action.
Authors: Hartmut Jaeschke; Gregory J Gores; Arthur I Cederbaum; Jack A Hinson; Dominique Pessayre; John J Lemasters Journal: Toxicol Sci Date: 2002-02 Impact factor: 4.849
Authors: Lucas Liaudet; Kanneganti G K Murthy; Jon G Mabley; Pál Pacher; Francisco G Soriano; Andrew L Salzman; Csaba Szabó Journal: Infect Immun Date: 2002-01 Impact factor: 3.441
Authors: Michel David dos Santos; Maria Camila Almeida; Norberto Peporine Lopes; Glória Emília Petto de Souza Journal: Biol Pharm Bull Date: 2006-11 Impact factor: 2.233
Authors: Rebecca M Minter; Xiaoming Bi; Gal Ben-Josef; Tianyi Wang; Bin Hu; Saman Arbabi; Mark R Hemmila; Stewart C Wang; Daniel G Remick; Grace L Su Journal: Am J Physiol Gastrointest Liver Physiol Date: 2008-10-23 Impact factor: 4.052
Authors: Agnieszka J Connor; Li C Chen; Laurie B Joseph; Jeffrey D Laskin; Debra L Laskin Journal: Exp Mol Pathol Date: 2012-09-19 Impact factor: 3.362
Authors: André T Shimoyama; José Roberto Santin; Isabel D Machado; Ana Mara de Oliveira e Silva; Illana L Pereira de Melo; Jorge Mancini-Filho; Sandra H P Farsky Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2012-11-06 Impact factor: 3.000